GlassScriptPhysician profile
Kimberly E Muchori
NPI 1528724804
$651.52
in general payments reported to CMS, 2019-2025
16 companies · $152 in 2025
The $152 reported for 2025 was less than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $81.60 · 2023: $215 · 2024: $203 · 2025: $152.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $570.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $569.92 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $101.57 | 2023-2024 | Verquvo, Belsomra |
| Amgen INC. | $89.70 | 2023-2025 | Repatha, Krystexxa, Otezla |
| Pfizer INC. | $82.80 | 2022-2024 | |
| Lilly USA, LLC | $71.82 | 2022-2025 | Mounjaro, Zepbound |
| Mannkind Corporation | $41.73 | 2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $40.26 | 2024 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $39.52 | 2022-2023 | |
| Bioxcel Therapeutics, INC. | $35.90 | 2023 | Igalmi |
| Abbvie INC. | $27.14 | 2025 | |
| Novo Nordisk INC | $24.03 | 2023 | Ozempic, Rybelsus |
| Shield Therapeutics INC | $19.53 | 2023 | Accrufer |
| Lucid Diagnostics INC. | $19.38 | 2022 | |
| Dexcom, INC. | $16.33 | 2025 | Dexcom G6 Transmitter |
| Idorsia Pharmaceuticals US INC | $14.34 | 2023 | Quviviq |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $14.30 | 2025 | Xifaxan |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $13.17 | 2023 | Jardiance |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kimberly Muchori listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.